304 related articles for article (PubMed ID: 21232723)
1. Evaluation of infarct-related coronary artery patency and microcirculatory function after facilitated percutaneous primary coronary angioplasty: the FINESSE-ANGIO (Facilitated Intervention With Enhanced Reperfusion Speed to Stop Events-Angiographic) study.
Prati F; Petronio S; Van Boven AJ; Tendera M; De Luca L; de Belder MA; Galassi AR; Imola F; Montalescot G; Peruga JZ; Barnathan ES; Ellis S; Savonitto S;
JACC Cardiovasc Interv; 2010 Dec; 3(12):1284-91. PubMed ID: 21232723
[TBL] [Abstract][Full Text] [Related]
2. Facilitated percutaneous coronary intervention versus primary percutaneous coronary intervention: design and rationale of the Facilitated Intervention with Enhanced Reperfusion Speed to Stop Events (FINESSE) trial.
Ellis SG; Armstrong P; Betriu A; Brodie B; Herrmann H; Montalescot G; Neumann FJ; Smith JJ; Topol E;
Am Heart J; 2004 Apr; 147(4):E16. PubMed ID: 15077099
[TBL] [Abstract][Full Text] [Related]
3. Enoxaparin in primary and facilitated percutaneous coronary intervention A formal prospective nonrandomized substudy of the FINESSE trial (Facilitated INtervention with Enhanced Reperfusion Speed to Stop Events).
Montalescot G; Ellis SG; de Belder MA; Janssens L; Katz O; Pluta W; Ecollan P; Tendera M; van Boven AJ; Widimsky P; Andersen HR; Betriu A; Armstrong P; Brodie BR; Herrmann HC; Neumann FJ; Effron MB; Lu J; Barnathan ES; Topol EJ;
JACC Cardiovasc Interv; 2010 Feb; 3(2):203-12. PubMed ID: 20170878
[TBL] [Abstract][Full Text] [Related]
4. Randomized early versus late abciximab in acute myocardial infarction treated with primary coronary intervention (RELAx-AMI Trial).
Maioli M; Bellandi F; Leoncini M; Toso A; Dabizzi RP
J Am Coll Cardiol; 2007 Apr; 49(14):1517-24. PubMed ID: 17418289
[TBL] [Abstract][Full Text] [Related]
5. Comparison of abciximab and eptifibatide on angiographic and clinical outcomes in rescue percutaneous coronary intervention for failed fibrinolytic therapy.
Bajaj RR; Mohammad A; Hong T; Irfan A; Sharieff W; Bagnall A; Christie JA; Kutryk MJ; Chisholm RJ; Cheema AN
J Invasive Cardiol; 2010 Aug; 22(8):347-52. PubMed ID: 20679668
[TBL] [Abstract][Full Text] [Related]
6. [Assessment of myocardial reperfusion in patients with acute myocardial infarction treated with combination of fibrinolysis and IIb/IIIa platelet inhibitor].
Dudek D; Bartuś S; Zmudka K; Kuta M; Legutko J; Wizimirski M; Pieniazek P; Przewłocki T; Gajos G; Bryniarski L; Dragan J; Pasowicz M; Zorkun C; Dubiel JS
Przegl Lek; 2002; 59(1):1-6. PubMed ID: 12108039
[TBL] [Abstract][Full Text] [Related]
7. Impact of infarct related artery patency after early abciximab administration on one-year mortality in patients with ST-segment elevation myocardial infarction (data from the EUROTRANSFER Registry).
Rakowski T; Siudak Z; Dziewierz A; Birkemeyer R; Janzon M; Mielecki W; Zmudka K; Dubiel JS; Dudek D
Kardiol Pol; 2012; 70(3):215-21. PubMed ID: 22430397
[TBL] [Abstract][Full Text] [Related]
8. Facilitated primary coronary intervention with abciximab and very low dose of alteplase during off-hours compared with direct primary intervention during regular hours.
Maioli M; Gallopin M; Leoncini M; Bellandi F; Toso A; Dabizzi RP
Catheter Cardiovasc Interv; 2005 Aug; 65(4):484-91. PubMed ID: 15973688
[TBL] [Abstract][Full Text] [Related]
9. Prospective randomised study to evaluate effectiveness of distal embolic protection compared to abciximab administration in reduction of microembolic complications of primary coronary angioplasty.
Ochała A; Smolka G; Wojakowski W; Gabrylewicz B; Garbocz P; Tendera M
Kardiol Pol; 2007 Jun; 65(6):672-80; discussion 681-3. PubMed ID: 17629829
[TBL] [Abstract][Full Text] [Related]
10. Increase of myocardial salvage and left ventricular function recovery with intracoronary abciximab downstream of the coronary occlusion in patients with acute myocardial infarction treated with primary coronary intervention.
Bellandi F; Maioli M; Gallopin M; Toso A; Dabizzi RP
Catheter Cardiovasc Interv; 2004 Jun; 62(2):186-92. PubMed ID: 15170708
[TBL] [Abstract][Full Text] [Related]
11. 1-year survival in a randomized trial of facilitated reperfusion: results from the FINESSE (Facilitated Intervention with Enhanced Reperfusion Speed to Stop Events) trial.
Ellis SG; Tendera M; de Belder MA; van Boven AJ; Widimsky P; Andersen HR; Betriu A; Savonitto S; Adamus J; Peruga JZ; Hamankiewicz M; Pluta W; Oldroyd K; Ecollan P; Janssens L; Armstrong P; Brodie BR; Herrmann HC; Montalescot G; Neumann FJ; Effron MB; Barnathan ES; Topol EJ;
JACC Cardiovasc Interv; 2009 Oct; 2(10):909-16. PubMed ID: 19850248
[TBL] [Abstract][Full Text] [Related]
12. Early administration of abciximab bolus in the emergency department improves angiographic outcome after primary PCI as assessed by TIMI frame count: results of the early ReoPro administration in myocardial infarction (ERAMI) trial.
Gabriel HM; Oliveira JA; da Silva PC; da Costa JM; da Cunha JA
Catheter Cardiovasc Interv; 2006 Aug; 68(2):218-24. PubMed ID: 16817177
[TBL] [Abstract][Full Text] [Related]
13. Benefit of facilitated percutaneous coronary intervention in high-risk ST-segment elevation myocardial infarction patients presenting to nonpercutaneous coronary intervention hospitals.
Herrmann HC; Lu J; Brodie BR; Armstrong PW; Montalescot G; Betriu A; Neuman FJ; Effron MB; Barnathan ES; Topol EJ; Ellis SG;
JACC Cardiovasc Interv; 2009 Oct; 2(10):917-24. PubMed ID: 19850249
[TBL] [Abstract][Full Text] [Related]
14. Facilitation of early percutaneous coronary intervention after reteplase with or without abciximab in acute myocardial infarction: results from the SPEED (GUSTO-4 Pilot) Trial.
Herrmann HC; Moliterno DJ; Ohman EM; Stebbins AL; Bode C; Betriu A; Forycki F; Miklin JS; Bachinsky WB; Lincoff AM; Califf RM; Topol EJ
J Am Coll Cardiol; 2000 Nov; 36(5):1489-96. PubMed ID: 11079647
[TBL] [Abstract][Full Text] [Related]
15. Predictors and implications of coronary infarct artery patency at initial angiography in patients with acute myocardial infarction (from the CADILLAC and HORIZONS-AMI Trials).
Brener SJ; Mehran R; Brodie BR; Guagliumi G; Witzenbichler B; Cristea E; Xu K; Lansky AJ; Stone GW
Am J Cardiol; 2011 Oct; 108(7):918-23. PubMed ID: 21764028
[TBL] [Abstract][Full Text] [Related]
16. Early abciximab administration in acute myocardial infarction treated with primary coronary intervention.
Bellandi F; Maioli M; Leoncini M; Toso A; Dabizzi RP
Int J Cardiol; 2006 Mar; 108(1):36-42. PubMed ID: 15927285
[TBL] [Abstract][Full Text] [Related]
17. Multicenter randomized trial of facilitated percutaneous coronary intervention with low-dose tenecteplase in patients with acute myocardial infarction: the Athens PCI trial.
Kanakakis J; Nanas JN; Tsagalou EP; Maroulidis GD; Drakos SG; Ntalianis AS; Tzoumele P; Skoumbourdis E; Charbis P; Rokas S; Anastasiou-Nana M
Catheter Cardiovasc Interv; 2009 Sep; 74(3):398-405. PubMed ID: 19360864
[TBL] [Abstract][Full Text] [Related]
18. Early treatment with abciximab in patients with ST elevation myocardial infarction results in a high rate of normal or near normal blood flow in the infarct related artery.
Tödt T; Sederholm-Lawesson S; Stenestrand U; Alfredsson J; Janzon M; Swahn E
Acute Card Care; 2010 Mar; 12(1):10-7. PubMed ID: 20201657
[TBL] [Abstract][Full Text] [Related]
19. The relationship between neutrophil/lymphocyte ratio and infarct-related artery patency before mechanical reperfusion in patients with ST-elevation myocardial infarction.
Kurtul A; Murat SN; Yarlioglues M; Duran M; Karadeniz M; Ergun G; Ocek AH
Coron Artery Dis; 2014 Mar; 25(2):159-66. PubMed ID: 24326783
[TBL] [Abstract][Full Text] [Related]
20. Facilitation of primary coronary angioplasty by early start of a glycoprotein 2b/3a inhibitor: results of the ongoing tirofiban in myocardial infarction evaluation (On-TIME) trial.
van 't Hof AW; Ernst N; de Boer MJ; de Winter R; Boersma E; Bunt T; Petronio S; Marcel Gosselink AT; Jap W; Hollak F; Hoorntje JC; Suryapranata H; Dambrink JH; Zijlstra F;
Eur Heart J; 2004 May; 25(10):837-46. PubMed ID: 15140531
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
